BOOK
Advanced Lung Cancer: Radical Surgical Therapy, An Issue of Thoracic Surgery Clinics, E-Book
(2014)
Additional Information
Book Details
Abstract
This issue of Thoracic Surgery Clinics is devoted to "Advanced Lung Cancer: Radical Surgical Therapy" and is edited by Dr. Raja M. Flores. Articles in this outstanding issue include: Surgical Resection of Lung Cancer in the Elderly; Extended Chest Wall Resection and Reconstruction in the Setting of Lung Cancer; The Management of Non–Small Cell Lung Cancer with Oligometastases; Lung Resection in Patients with Marginal Pulmonary Function; Surgery for Small Cell Lung Cancer; Bronchial and Arterial Sleeve Resection after Induction Therapy for Lung Cancer; Advanced Lung Cancer: Aggressive Surgical Therapy Vertebral Body Involvement; Pulmonary Resection after Pneumonectomy; Superior Vena Caval Resection in Lung Cancer; Surgical Resection of Non-Small Cell Lung Cancer with N2 Disease; Lung Transplantation for Multifocal Lung Adenocarcinoma; Extended Resections of Non-Small Cell Lung Cancers Invading the Aorta, Pulmonary Artery, Left Atrium or Esophagus: Can They Be Justified?; VATS Lobectomy after Induction Therapy; Extrapleural Pneumonectomy for Pleural Disease; Carinal Resection, and more!
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Advanced Lung Cancer:Radical Surgical Therapy | i | ||
Copyright\r | ii | ||
Contributors | iii | ||
Contents | vii | ||
Thoracic Surgery Clinics\r | xi | ||
Preface\r\r | xiii | ||
Erratum | xv | ||
Lung Resection in Patients with Marginal Pulmonary Function | 361 | ||
Key points | 361 | ||
Introduction | 361 | ||
Historical context | 361 | ||
Current guidelines | 362 | ||
Worst-case forced expiratory volume in the first second of expiration | 362 | ||
Specific considerations | 362 | ||
Minimally invasive surgery | 362 | ||
Anatomic considerations | 366 | ||
Sublobar resections | 366 | ||
Discussion | 367 | ||
Summary | 369 | ||
References | 369 | ||
Surgical Resection of Lung Cancer in the Elderly | 371 | ||
Key points | 371 | ||
Introduction: nature of the problem | 371 | ||
Therapeutic options and/or surgical techniques | 372 | ||
Clinical outcomes and the preoperative assessment | 373 | ||
Physiologic Changes of Age | 373 | ||
Preoperative Evaluation | 373 | ||
Cardiac Risk Assessment | 374 | ||
Pulmonary Risk Assessment | 374 | ||
Cognitive Assessment | 376 | ||
Geriatric Assessments | 376 | ||
Complications and Concerns | 377 | ||
Practical Recommendations | 378 | ||
Summary | 379 | ||
References | 379 | ||
Extended Chest Wall Resection and Reconstruction in the Setting of Lung Cancer | 383 | ||
Key points | 383 | ||
Introduction | 383 | ||
Preoperative Diagnosis and Staging | 383 | ||
Neoadjuvant Therapy | 384 | ||
Preoperative Planning | 384 | ||
Resection and surgical technique | 384 | ||
Surgical Technique | 384 | ||
Positioning and Incision | 384 | ||
Chest Wall Resection | 385 | ||
En Bloc Resection | 385 | ||
Reconstruction | 385 | ||
General Considerations | 385 | ||
Mesh Repair | 385 | ||
Methyl Methacrylate | 386 | ||
Riblike Method | 386 | ||
Titanium Ribs | 386 | ||
Biologics | 386 | ||
Titanium Mesh | 387 | ||
Soft Tissue Coverage | 387 | ||
Clinical outcomes | 388 | ||
Survival (Lung Cancer) | 388 | ||
Functional | 388 | ||
Complications and Concerns | 388 | ||
Summary | 389 | ||
References | 389 | ||
The Management of Non–Small Cell Lung Cancer With Oligometastases | 391 | ||
Key points | 391 | ||
Introduction | 391 | ||
Background | 391 | ||
Extent of the problem: percentage of patients with non–small cell lung cancer with oligometastatic disease | 392 | ||
The present | 393 | ||
Lung metastases | 393 | ||
Cerebral metastases | 394 | ||
Adrenal metastases | 394 | ||
Completed clinical trials | 395 | ||
Future directions | 395 | ||
Summary | 396 | ||
References | 396 | ||
Surgery for Small Cell Lung Cancer | 399 | ||
Key points | 399 | ||
Staging of SCLC | 400 | ||
Patterns of failure in treated SCLC | 401 | ||
Evidence supporting surgery for SCLC | 401 | ||
Prospective Randomized Trials | 401 | ||
Prospective Nonrandomized Trials | 402 | ||
Institutional Retrospective Reviews | 403 | ||
National Cancer Database Reviews | 403 | ||
Indications for surgery | 405 | ||
T1-2N0 Disease | 405 | ||
Solitary Pulmonary Nodules (SPN) | 406 | ||
Combined Histology Tumors | 406 | ||
Salvage Surgery for Initial Treatment Failure or Relapse | 406 | ||
New Tumors in Survivors of SCLC | 406 | ||
Current guidelines and conclusions | 407 | ||
References | 408 | ||
Bronchial and Arterial Sleeve Resection After Induction Therapy for Lung Cancer | 411 | ||
Key points | 411 | ||
Introduction | 411 | ||
Indications and preoperative evaluation | 412 | ||
Operative technique | 413 | ||
Dissection Phase | 413 | ||
Resection and reconstruction phase | 414 | ||
Bronchial resection and reconstruction | 414 | ||
PA resection and reconstruction | 415 | ||
Partial Resection and Patch Reconstruction | 415 | ||
Sleeve Resection and Reconstruction by End-to-end Anastomosis | 415 | ||
Sleeve Resection and Reconstruction by a Prosthetic Conduit | 416 | ||
Complications and perioperative management | 416 | ||
Short-term and long-term results | 417 | ||
Comparison Between Bronchovascular Reconstructions and PN After Induction Therapy | 419 | ||
Impact on Postoperative Quality of Life | 420 | ||
Acknowledgments | 420 | ||
References | 420 | ||
Advanced Lung Cancer | 423 | ||
Key points | 423 | ||
Introduction | 423 | ||
NOMS decision framework for spine metastases | 424 | ||
NOMS assessment for NSCLC | 424 | ||
NSCLC without ESCC | 424 | ||
NSCLC with high-grade ESCC | 424 | ||
Mechanical instability | 425 | ||
Systemic disease and medical comorbidities | 426 | ||
Imaging spine tumors | 426 | ||
Surgical approaches | 427 | ||
Separation surgery | 427 | ||
Superior sulcus tumors with involvement of the spine | 428 | ||
Major Complications | 429 | ||
Instrumentation failure | 429 | ||
Wound dehiscence or infection | 429 | ||
Summary | 430 | ||
References | 430 | ||
Pulmonary Resection After Pneumonectomy | 433 | ||
Key points | 433 | ||
Introduction | 433 | ||
Selection of patients for resection | 434 | ||
Functional Status Evaluation and Cardiopulmonary Reserve | 434 | ||
Non–Small Cell Lung Caner Extension Assessment | 435 | ||
Surgical technique | 435 | ||
Anesthetic Management | 435 | ||
Surgical Procedure | 436 | ||
Clinical outcomes | 438 | ||
Alternatives to surgical management | 438 | ||
Summary | 438 | ||
References | 439 | ||
Superior Vena Caval Resection in Lung Cancer | 441 | ||
Key points | 441 | ||
Introduction | 441 | ||
Background | 441 | ||
Preoperative evaluation | 441 | ||
Therapeutic options and/or surgical techniques | 441 | ||
Complications and concerns | 445 | ||
Clinical outcomes | 446 | ||
Summary | 446 | ||
References | 446 | ||
Surgical Resection of Non–Small Cell Lung Cancer with N2 Disease | 449 | ||
Key points | 449 | ||
Introduction | 449 | ||
Extent of N2 disease | 449 | ||
Induction chemotherapy | 451 | ||
Induction chemoradiotherapy | 452 | ||
Morbidity and mortality after induction therapy | 453 | ||
Mediastinal restaging | 453 | ||
T4N2 disease | 454 | ||
Summary | 454 | ||
References | 454 | ||
Extended Resections of Non-small Cell Lung Cancers Invading the Aorta, Pulmonary Artery, Left Atrium, or Esophagus | 457 | ||
Key points | 457 | ||
Introduction | 457 | ||
Historical background | 457 | ||
More recent experience | 458 | ||
Extended resections | 460 | ||
Aorta | 460 | ||
Pulmonary Artery | 460 | ||
Left Atrium | 461 | ||
Esophagus | 462 | ||
Preoperative workup | 462 | ||
Neoadjuvant therapy | 462 | ||
Summary | 463 | ||
References | 463 | ||
Video-Assisted Thoracoscopic (VATS) Lobectomy After Induction Therapy | 465 | ||
Key points | 465 | ||
Introduction | 465 | ||
Outcomes | 465 | ||
Patient selection | 467 | ||
Technique | 468 | ||
References | 470 | ||
Extrapleural Pneumonectomy for Pleural Malignancies | 471 | ||
Key points | 471 | ||
Introduction | 471 | ||
History | 471 | ||
Pleural dissemination of malignancy | 472 | ||
Thymoma | 472 | ||
Sarcoma | 472 | ||
Pleural dissemination of nonsmall cell lung cancer | 472 | ||
Nonsmall Cell Lung Cancer Staging | 472 | ||
Mediastinal Nodal Disease | 472 | ||
Care of the extrapleural pneumonectomy patient | 473 | ||
Preoperative Assessment | 473 | ||
Perioperative Considerations | 474 | ||
Postoperative Care | 474 | ||
Summary | 474 | ||
References | 475 | ||
Carinal Resection | 477 | ||
Key points | 477 | ||
Introduction | 477 | ||
Indications | 477 | ||
Operative management | 478 | ||
Anesthesia | 478 | ||
Surgical Incisions | 479 | ||
Intraoperative Dissection | 479 | ||
Resections | 479 | ||
Carinal resection with right pneumonectomy/right upper lobectomy | 479 | ||
Carinal resection with left pneumonectomy | 479 | ||
Carinal resection without pulmonary resection | 480 | ||
Lesion confined to the carina: neocarina | 480 | ||
Carinal lesion with involvement of the distal trachea | 480 | ||
Reconstruction Technique | 482 | ||
General principles | 482 | ||
Specific aspects | 482 | ||
The end to side anastomosis | 482 | ||
Isolated neocarina, tracheal transplant | 482 | ||
Release Maneuvers | 483 | ||
Clinical outcomes | 483 | ||
Complications and concerns | 483 | ||
Acute Respiratory Distress Syndrome | 483 | ||
Anastomotic complications | 483 | ||
Summary | 484 | ||
Supplementary data | 484 | ||
References | 484 | ||
Lung Transplantation for Multifocal Lung Adenocarcinoma (Multifocal Lung Carcinoma) | 485 | ||
Key points | 485 | ||
Introduction | 485 | ||
Patient selection | 486 | ||
Bronchioloalveolar Carcinoma and Current Classification | 486 | ||
Lung transplantation | 487 | ||
Patient Outcomes | 487 | ||
Summary | 489 | ||
References | 490 | ||
Index | 493 |